Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Quality of Care Among Emerging Adults with Sickle Cell Disease Using the Ascq-ME Qoc Measure: Baseline ST3P-up Study Data Results

Ifeyinwa Osunkwo, Myra Robinson, Anya Griffin, Azizi Coleman, Sharvil Desai, Padmaja Veeramreddy, Payal Desai, Charity Patterson, James Symanowski, Paulette Bryant, Jennifer Cornette, Wally R Smith, James R Eckman, Ramona Lawrence

Blood (2023) 142 (Supplement 1): 5048.

https://doi.org/10.1182/blood-2023-186835

Published: 2023

Journal Articles

Successful Treatment with Emicizumab of Patient with Type 2N Normandy and Severe Hemophilia a

Paulette Bryant, Elizabeth Lineberger, Courtney Huckel Carr, Angela Kaus

Blood (2021) 138 (Supplement 1): 4249.

https://doi.org/10.1182/blood-2021-153096

Published: 2021

Journal Articles

Severe Bleeding Events in Hemophilia Α Patients Receiving Emicizumab Prophylaxis

Karen L. Zimowski, MD, Glaivy M. Batsuli, MD, Paulette Bryant, MD, Jenny McDaniel, MD, Kelly Tickle, MSN, APN, PPCNP-BC, Shannon L. Meeks, MD, Robert F. Sidonio, Jr., MD MSc

Blood (2019) 134 (Supplement_1): 1126.

https://doi.org/10.1182/blood-2019-126659

Published: 2019

Journal Articles

Interpretation of TEG Studies in Management of a Severe Glanzmann Thrombasthenia Patient

Paulette Bryant, MD, Katie Andricopulos, PharmD, BCPPS

Blood (2017) 130 (Supplement 1): 4854.

https://doi.org/10.1182/blood.V130.Suppl_1.4854.4854

Published: 2017

Journal Articles

Construction of An Outpatient Erythrocytapheresis Program for Pediatric Patients with Sickle Cell Disease

Paulette Bryant, MD, Richard Parmley, MD, Christine Bolen, MD, Theresa Sunderland, MD, Robert Johnson, MD, Jennifer Weisner, PNP, Karen Nishioka, BSN, Karen Roberts, RN, Richard Towell, RN, Jodi P. Strong, MBA, Evelyn Lockhart, MD, Mark Mogul, MD

Blood (2008) 112 (11): 4067.

https://doi.org/10.1182/blood.V112.11.4067.4067

Published: 2008

Journal Articles

Sequential Use of Recombinant Factor VIIa and FEIBA in a Pediatric Patient with Disseminated Intravascular Coagulation.

Paulette Bryant, MD, Theresa Sunderland, MD, Mark Mogul, MD

Blood (2006) 108 (11): 4066.

https://doi.org/10.1182/blood.V108.11.4066.4066

Published: 2006

NARROW

Quality of Care Among Emerging Adults with Sickle Cell Disease Using the Ascq-ME Qoc Measure: Baseline ST3P-up Study Data Results

Successful Treatment with Emicizumab of Patient with Type 2N Normandy and Severe Hemophilia a

Severe Bleeding Events in Hemophilia Α Patients Receiving Emicizumab Prophylaxis

Interpretation of TEG Studies in Management of a Severe Glanzmann Thrombasthenia Patient

Construction of An Outpatient Erythrocytapheresis Program for Pediatric Patients with Sickle Cell Disease

Sequential Use of Recombinant Factor VIIa and FEIBA in a Pediatric Patient with Disseminated Intravascular Coagulation.

Email alerts

ASH Publications

American Society of Hematology

Quality of Care Among Emerging Adults with Sickle Cell Disease Using the Ascq-ME Qoc Measure: Baseline ST3P-up Study Data Results

Successful Treatment with Emicizumab of Patient with Type 2N Normandy and Severe Hemophilia a

Severe Bleeding Events in Hemophilia Α Patients Receiving Emicizumab Prophylaxis

Interpretation of TEG Studies in Management of a Severe Glanzmann Thrombasthenia Patient

Construction of An Outpatient Erythrocytapheresis Program for Pediatric Patients with Sickle Cell Disease

Sequential Use of Recombinant Factor VIIa and FEIBA in a Pediatric Patient with Disseminated Intravascular Coagulation.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only